首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Bis(aminomethyl)phosphinicAcid a Highly PromisingScaffold for the Development of Bacterial Urease Inhibitors
【2h】

Bis(aminomethyl)phosphinicAcid a Highly PromisingScaffold for the Development of Bacterial Urease Inhibitors

机译:双(氨基甲基)次膦酸酸很有前途支架的细菌脲酶抑制剂的发展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Inhibitors of bacterial ureases are considered to be promising compounds in the treatment of infections caused by Helicobacter pylori in the gastric tract and/or by urealytic bacteria (e.g., Proteus species) in the urinary tract. A new, extended transition state scaffold, bis(aminomethyl)phosphinic acid, was successfully explored for the construction of effective enzyme inhibitors. A reliable methodology for the synthesis of phosphinate analogues in a three-component Mannich-type reaction was elaborated. The obtained molecules were assayed against ureases purified from Sporosarcina pasteurii and Proteus mirabilis, and aminomethyl(N-n-hexylaminomethyl)phosphinic acid was found to be the most potent inhibitor, with a Ki = 108 nM against the S. pasteurii enzyme.
机译:细菌脲酶抑制剂被认为是用于治疗由胃道中的幽门螺杆菌和/或尿道中的尿素分解细菌(例如变形杆菌属)引起的感染的有前途的化合物。一个新的扩展的过渡态支架,双(氨基甲基)次膦酸,已成功地探索了有效的酶抑制剂的建设。阐述了在三组分曼尼希型反应中合成次膦酸酯类似物的可靠方法。对获得的分子进行了针对从巴氏孢子虫和米氏变形杆菌纯化的脲酶的测定,发现氨基甲基(N-正己基氨基甲基)次膦酸是最有效的抑制剂,针对巴氏酵母的酶的Ki = 108 nM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号